 Nephros OTCMKTS:NEPH was upgraded by Zacks Investment Research from a sell rating to a hold rating in a research note issued on Wednesday, Zacks.com reports. According to Zacks, Nephros develops advanced End Stage Renal Disease, or ESRD, therapy technology and products that would address both patient treatment needs and the clinical and financial needs of ... 